Uwatoko et al., 1988 - Google Patents
Low-molecular weight C1q-binding immunoglobulin G in patients with systemic lupus erythematosus consists of autoantibodies to the collagen-like region of C1q.Uwatoko et al., 1988
View PDF- Document ID
- 12268390790161521012
- Author
- Uwatoko S
- Mannik M
- et al.
- Publication year
- Publication venue
- The Journal of clinical investigation
External Links
Snippet
The majority of C1q-binding IgG in sera of some patients with systemic lupus erythematosus (SLE) cosediments with monomeric IgG. This study was undertaken to provide definitive proof that the low-molecular weight C1q-binding IgG consists of autoantibodies to C1q …
- 230000027455 binding 0 title abstract description 148
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/564—Immunoassay; Biospecific binding assay for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Uwatoko et al. | Low-molecular weight C1q-binding immunoglobulin G in patients with systemic lupus erythematosus consists of autoantibodies to the collagen-like region of C1q. | |
Simon et al. | The cytokeratin filament-aggregating protein filaggrin is the target of the so-called | |
Panitch et al. | CSF antibody to myelin basic protein: measurement in patients with multiple sclerosis and subacute sclerosing panencephalitis | |
Coulter et al. | Enzyme immunoassay for the rapid clinical identification of snake venom | |
Schlossman et al. | Specific fractionation of a population of antidextran molecules with combining sites of various sizes | |
Siegert et al. | IgG and IgA antibodies to the collagen‐like region of C1q in rheumatoid vasculitis | |
Vallota et al. | A serum factor in chronic hypocomplementemic nephritis distinct from immunoglobulins and activating the alternate pathway of complement | |
Clayman et al. | Isolation and characterization of the nephritogenic antigen producing anti-tubular basement membrane disease. | |
US4544640A (en) | Anti immune complex antibody for determining SLE, rheumatoid arthritis or tetanus | |
Okret et al. | Characterization of an antiserum against the glucocorticoid receptor | |
Fujisawa et al. | Platelet-associated antibody to glycoprotein IIb/IIIa from chronic immune thrombocytopenic purpura patients often binds to divalent cation-dependent antigens | |
Boehm et al. | Systemic lupus erythematosus is associated with increased auto‐antibody titers against calreticulin and grp94, but calreticulin is not the Ro/SS‐A antigen | |
Muller et al. | Autoantibodies reacting with poly (ADP-ribose) and with a zinc-finger functional domain of poly (ADP-ribose) polymerase involved in the recognition of damaged DNA | |
Kleppel et al. | Immunochemical studies of the Alport antigen | |
MARcus et al. | The occurrence of cryoproteins in synovial fluid; the association of a complement-fixing activity in rheumatoid synovial fluid with cold-precipitable protein | |
Fish et al. | Detection of Goodpasture antigen in fractions prepared from collagenase digests of human glomerular basement membrane. | |
Vidal et al. | Alternative mechanism of protein A-immunoglobulin interaction the VH-associated reactivity of a monoclonal human IgM. | |
Uwatoko et al. | The location of binding sites on C1q for DNA. | |
Waldo et al. | Mixed IgA-IgG aggregates as a model of immune complexes in IgA nephropathy. | |
JPS62501563A (en) | Proteins characteristic of rheumatoid arthritis | |
AU679443B2 (en) | Methods and reagents for diagnosis of autoantibodies | |
Parham | Changes in conformation with loss of alloantigenic determinants of a histocompatibility antigen (HLA-B7) induced by monoclonal antibodies. | |
Bartlow et al. | Nonimmunoglobulin C3 activating factor in membranoproliferative glomerulonephritis | |
US5891436A (en) | Primary biliary cirrhosis autoantigen and method of use | |
Ostberg et al. | Independent expression of the two HL‐A antigen polypeptide chains |